Publications

Impact of Prior Therapy on the Efficacy and Safety of Oral Ixazomib-Lenalidomide-Dexamethasone Vs. Placebo-Lenalidomide-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma in Tourmaline-Mm1

AuthID
P-00N-2VR

Author(s)

Mateos, MV

Masszi, T

Grzasko, N

Hansson, M

Sandhu, I

Pour, L

Viterbo, L

Jackson, SR

Stoppa, AM

Gimsing, P

Hamadani, M

Borsaru, G

Berg, D

Lin, JC

Di Bacco, A

van de Velde, H

Richardson, PG

Moreau, P

Document Type

Article

Year published

2017

Published

in HAEMATOLOGICA, ISSN: 0390-6078

Volume: 102, Issue: 10, Pages: 1767-1775 (9)

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.3324/haematol.2017.170118

SCOPUS: 2-s2.0-85030316883

Wos: WOS:000411964200029

Source Identifiers

ISSN: 0390-6078

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Impact of Prior Therapy on the Efficacy and Safety of Oral Ixazomib-Lenalidomide-Dexamethasone Vs. Placebo-Lenalidomide-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma in Tourmaline-Mm1

Useful Links

Get Help

Federated Authentication (Click on the image)

Impact of Prior Therapy on the Efficacy and Safety of Oral Ixazomib-Lenalidomide-Dexamethasone Vs. Placebo-Lenalidomide-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma in Tourmaline-Mm1

Useful Links

Get Help